These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20095795)

  • 41. Evaluation and treatment of GERD and upper GI complaints in athletes.
    Leggit JC
    Curr Sports Med Rep; 2011; 10(2):109-14. PubMed ID: 21623293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment patterns in paediatric patients with a new diagnosis of gastroesophageal reflux disease.
    Ruigómez A; Hungin AP; Lundborg P; Johansson S; Wallander MA; García Rodríguez LA
    Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):232-7. PubMed ID: 21258240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical trial: acupuncture vs. doubling the proton pump inhibitor dose in refractory heartburn.
    Dickman R; Schiff E; Holland A; Wright C; Sarela SR; Han B; Fass R
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1333-44. PubMed ID: 17875198
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Primary-care physicians' perceptions and practices on the management of GERD: results of a national survey.
    Chey WD; Inadomi JM; Booher AM; Sharma VK; Fendrick AM; Howden CW
    Am J Gastroenterol; 2005 Jun; 100(6):1237-42. PubMed ID: 15929751
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Gastroesophageal reflux disease in pregnancy].
    Nikolov A; Pevtichev S; Petrova D
    Akush Ginekol (Sofiia); 2013; 52(7):35-40. PubMed ID: 24505639
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both?
    Tack J; Koek G; Demedts I; Sifrim D; Janssens J
    Am J Gastroenterol; 2004 Jun; 99(6):981-8. PubMed ID: 15180713
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors.
    Zerbib F; Duriez A; Roman S; Capdepont M; Mion F
    Gut; 2008 Feb; 57(2):156-60. PubMed ID: 17951358
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease.
    Savarino E; Marabotto E; Zentilin P; Frazzoni M; Sammito G; Bonfanti D; Sconfienza L; Assandri L; Gemignani L; Malesci A; Savarino V
    Dig Liver Dis; 2011 Jul; 43(7):542-7. PubMed ID: 21376679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New algorithm for the treatment of gastro-oesophageal reflux disease.
    Tytgat GN; McColl K; Tack J; Holtmann G; Hunt RH; Malfertheiner P; Hungin AP; Batchelor HK
    Aliment Pharmacol Ther; 2008 Feb; 27(3):249-56. PubMed ID: 17973975
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors.
    Boardman HF; Heeley G
    Int J Clin Pharm; 2015 Oct; 37(5):709-16. PubMed ID: 26100836
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease.
    Bytzer P; Jones R; Vakil N; Junghard O; Lind T; Wernersson B; Dent J
    Clin Gastroenterol Hepatol; 2012 Dec; 10(12):1360-6. PubMed ID: 22813439
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functional heartburn: clinical characteristics and outcome.
    Surdea Blaga T; Dumitrascu D; Galmiche JP; Bruley des Varannes S
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):282-90. PubMed ID: 23128061
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Managing heartburn and reflux in primary care.
    Provenza D; Gillette C; Peacock B; Rejeski J
    JAAPA; 2024 Mar; 37(3):24-29. PubMed ID: 38349081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heartburn: picking the right remedy.
    Consum Rep; 2002 Sep; 68(9):42-5. PubMed ID: 12187951
    [No Abstract]   [Full Text] [Related]  

  • 55. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nonprescription Heartburn Medications for Adults.
    Vordenberg SE
    JAMA; 2023 Oct; 330(15):1499. PubMed ID: 37773509
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Knowledge gaps in the management of refractory reflux-like symptoms: Healthcare provider survey.
    Armstrong D; Hungin AP; Kahrilas PJ; Sifrim D; Sinclair P; Vaezi MF; Sharma P
    Neurogastroenterol Motil; 2022 Oct; 34(10):e14387. PubMed ID: 35502888
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gastroesophageal reflux disease (GERD): is there more to the story?
    Vesper BJ; Altman KW; Elseth KM; Haines GK; Pavlova SI; Tao L; Tarjan G; Radosevich JA
    ChemMedChem; 2008 Apr; 3(4):552-9. PubMed ID: 18076011
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heartburn, gastroesophageal reflux (GER), and gastroesophageal reflux disease (GERD).
    J Pract Nurs; 2008; 58(3):21-3. PubMed ID: 19180847
    [No Abstract]   [Full Text] [Related]  

  • 60. Double-blind, placebo-controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy.
    Larson JD; Patatanian E; Miner PB; Rayburn WF; Robinson MG
    Obstet Gynecol; 1997 Jul; 90(1):83-7. PubMed ID: 9207819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.